BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lukiw WJ, Pogue A, Hill JM. SARS-CoV-2 Infectivity and Neurological Targets in the Brain. Cell Mol Neurobiol 2020. [PMID: 32840758 DOI: 10.1007/s10571-020-00947-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 18.5] [Reference Citation Analysis]
Number Citing Articles
1 Mauriz E, Lechuga LM. Current Trends in SPR Biosensing of SARS-CoV-2 Entry Inhibitors. Chemosensors 2021;9:330. [DOI: 10.3390/chemosensors9120330] [Reference Citation Analysis]
2 Schober ME, Robertson CL, Wainwright MS, Roa JD, Fink EL. COVID-19 and the Pediatric Nervous System: Global Collaboration to Meet a Global Need. Neurocrit Care 2021. [PMID: 34184177 DOI: 10.1007/s12028-021-01269-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Reza-Zaldívar EE, Hernández-Sapiéns MA, Minjarez B, Gómez-Pinedo U, Márquez-Aguirre AL, Mateos-Díaz JC, Matias-Guiu J, Canales-Aguirre AA. Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System. Front Immunol 2020;11:621735. [PMID: 33584720 DOI: 10.3389/fimmu.2020.621735] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
4 Lukiw WJ, Vergallo A, Lista S, Hampel H, Zhao Y. Biomarkers for Alzheimer's Disease (AD) and the Application of Precision Medicine. J Pers Med 2020;10:E138. [PMID: 32967128 DOI: 10.3390/jpm10030138] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
5 Rothan HA, Kumari P, Stone S, Natekar JP, Arora K, Auroni TT, Kumar M. SARS-CoV-2 Infects Primary Neurons from Human ACE2 Expressing Mice and Upregulates Genes Involved in the Inflammatory and Necroptotic Pathways. Pathogens 2022;11:257. [DOI: 10.3390/pathogens11020257] [Reference Citation Analysis]
6 Toniolo S, Di Lorenzo F, Scarioni M, Frederiksen KS, Nobili F. Is the Frontal Lobe the Primary Target of SARS-CoV-2? J Alzheimers Dis 2021;81:75-81. [PMID: 33720900 DOI: 10.3233/JAD-210008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
7 Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53:737-54. [PMID: 34024217 DOI: 10.1080/23744235.2021.1924397] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
8 Alschuler L, Chiasson AM, Horwitz R, Sternberg E, Crocker R, Weil A, Maizes V. Integrative medicine considerations for convalescence from mild-to-moderate COVID-19 disease. Explore (NY) 2020:S1550-8307(20)30417-1. [PMID: 33358750 DOI: 10.1016/j.explore.2020.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
9 Tavčar P, Potokar M, Kolenc M, Korva M, Avšič-Županc T, Zorec R, Jorgačevski J. Neurotropic Viruses, Astrocytes, and COVID-19. Front Cell Neurosci 2021;15:662578. [PMID: 33897376 DOI: 10.3389/fncel.2021.662578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Gupta A, Marzook H, Ahmad F. Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview. Clin Exp Med 2022. [PMID: 35362771 DOI: 10.1007/s10238-022-00821-4] [Reference Citation Analysis]
11 Hayley S, Sun H. Neuroimmune multi-hit perspective of coronaviral infection. J Neuroinflammation 2021;18:231. [PMID: 34645457 DOI: 10.1186/s12974-021-02282-0] [Reference Citation Analysis]
12 Czapski GA, Zhao Y, Lukiw WJ, Strosznajder JB. Acute Systemic Inflammatory Response Alters Transcription Profile of Genes Related to Immune Response and Ca2+ Homeostasis in Hippocampus; Relevance to Neurodegenerative Disorders. Int J Mol Sci 2020;21:E7838. [PMID: 33105802 DOI: 10.3390/ijms21217838] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
13 Jaiswal V, Alquraish D, Sarfraz Z, Sarfraz A, Nagpal S, Singh Shrestha P, Mukherjee D, Guntipalli P, Sánchez Velazco DF, Bhatnagar A, Savani S, Halilaj E, Ruxmohan S, Cueva W. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review. J Prim Care Community Health 2021;12:21501327211039709. [PMID: 34404266 DOI: 10.1177/21501327211039709] [Reference Citation Analysis]
14 Engin AB, Engin ED, Engin A. Current opinion in neurological manifestations of SARS-CoV-2 infection. Curr Opin Toxicol 2021;25:49-56. [PMID: 33817451 DOI: 10.1016/j.cotox.2021.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Sugiyama A, Miwata K, Kitahara Y, Okimoto M, Abe K, E B, Ouoba S, Akita T, Tanimine N, Ohdan H, Kubo T, Nagasawa A, Nakanishi T, Takafuta T, Tanaka J. Long COVID occurrence in COVID-19 survivors. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-10051-z] [Reference Citation Analysis]
16 Quarleri J, Delpino MV. SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients. Geroscience 2022. [PMID: 35157210 DOI: 10.1007/s11357-022-00528-0] [Reference Citation Analysis]
17 Mao L, Chen Z, Wang Y, Chen C. Design and application of nanoparticles as vaccine adjuvants against human corona virus infection. J Inorg Biochem 2021;219:111454. [PMID: 33878530 DOI: 10.1016/j.jinorgbio.2021.111454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tan LY, Komarasamy TV, Rmt Balasubramaniam V. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword. Front Immunol 2021;12:742941. [PMID: 34659238 DOI: 10.3389/fimmu.2021.742941] [Reference Citation Analysis]
19 Pyne JD, Brickman AM. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline. Neurodegener Dis 2021;21:1-23. [PMID: 34348321 DOI: 10.1159/000518581] [Reference Citation Analysis]
20 Rodríguez-Rodríguez MS, Romero-Castro RM, Alvarado-de la Barrera C, González-Cannata MG, García-Morales AK, Ávila-Ríos S. Optic neuritis following SARS-CoV-2 infection. J Neurovirol 2021;27:359-63. [PMID: 33755923 DOI: 10.1007/s13365-021-00959-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Orendáčová M, Kvašňák E. Possible Mechanisms Underlying Neurological Post-COVID Symptoms and Neurofeedback as a Potential Therapy. Front Hum Neurosci 2022;16:837972. [DOI: 10.3389/fnhum.2022.837972] [Reference Citation Analysis]
22 Novelli G, Biancolella M, Mehrian-Shai R, Erickson C, Godri Pollitt KJ, Vasiliou V, Watt J, Reichardt JKV. COVID-19 update: the first 6 months of the pandemic. Hum Genomics 2020;14:48. [PMID: 33357238 DOI: 10.1186/s40246-020-00298-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
23 Shafiee S, Cegolon L, Khafaei M, Gholami N, Zhao S, Khalesi N, Moosavian H, Fathi S, Izadi M, Ghadian A, Javanbakht M, Javanbakht A, Akhavan-Sigari R. Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19. Cancer Cell Int 2021;21:431. [PMID: 34399734 DOI: 10.1186/s12935-021-02129-x] [Reference Citation Analysis]
24 Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res Ther 2020;12:170. [PMID: 33380345 DOI: 10.1186/s13195-020-00744-w] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
25 Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol 2021;12:698169. [PMID: 34248921 DOI: 10.3389/fmicb.2021.698169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
26 Yong SJ. Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis. ACS Chem Neurosci 2021;12:573-80. [PMID: 33538586 DOI: 10.1021/acschemneuro.0c00793] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
27 Ingersoll JG. Observations on the Occurrence, Transmission and Management of the COVID-19 Pandemic Derived from Physics. Diseases 2021;9:9. [PMID: 33467041 DOI: 10.3390/diseases9010009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Cárdenas-Rodríguez N, Bandala C, Vanoye-Carlo A, Ignacio-Mejía I, Gómez-Manzo S, Hernández-Cruz EY, Pedraza-Chaverri J, Carmona-Aparicio L, Hernández-Ochoa B. Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19. Antioxidants (Basel) 2021;10:971. [PMID: 34204362 DOI: 10.3390/antiox10060971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Gedik Ö, Hüsam H, Başöz M, Tas N, Aksoy F. The effect of coronavirus disease 2019 on the hearing system. J Laryngol Otol 2021;135:810-4. [PMID: 34344488 DOI: 10.1017/S0022215121001961] [Reference Citation Analysis]
30 Nori S, Moran A, Franolich J, Patel J, Stern M. COVID-19 and Neurologic Manifestations: An Experience at Major New York City Hospitals. Cureus. [DOI: 10.7759/cureus.24049] [Reference Citation Analysis]
31 Schober ME, Pavia AT, Bohnsack JF. Neurologic Manifestations of COVID-19 in Children: Emerging Pathophysiologic Insights. Pediatr Crit Care Med 2021;22:655-61. [PMID: 33965992 DOI: 10.1097/PCC.0000000000002774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Whitmore HAB, Kim LA. Understanding the Role of Blood Vessels in the Neurologic Manifestations of Coronavirus Disease 2019 (COVID-19). Am J Pathol 2021:S0002-9440(21)00260-1. [PMID: 34126084 DOI: 10.1016/j.ajpath.2021.04.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Wan D, Du T, Hong W, Chen L, Que H, Lu S, Peng X. Neurological complications and infection mechanism of SARS-COV-2. Signal Transduct Target Ther 2021;6:406. [PMID: 34815399 DOI: 10.1038/s41392-021-00818-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Jiang DH, Roy DJ, Gu BJ, Hassett LC, McCoy RG. Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A State-of-the-Art Review. JACC Basic Transl Sci 2021;6:796-811. [PMID: 34541421 DOI: 10.1016/j.jacbts.2021.07.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 [DOI: 10.1101/2020.12.14.422714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
36 Jęśko H, Wieczorek I, Wencel PL, Gąssowska-Dobrowolska M, Lukiw WJ, Strosznajder RP. Age-Related Transcriptional Deregulation of Genes Coding Synaptic Proteins in Alzheimer's Disease Murine Model: Potential Neuroprotective Effect of Fingolimod. Front Mol Neurosci 2021;14:660104. [PMID: 34305524 DOI: 10.3389/fnmol.2021.660104] [Reference Citation Analysis]
37 Fujimura Y, Holland LZ. COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm. Int J Hematol 2022. [PMID: 35316498 DOI: 10.1007/s12185-022-03324-w] [Reference Citation Analysis]
38 Lukiw WJ. microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection-A Commentary. Noncoding RNA 2021;7:37. [PMID: 34207055 DOI: 10.3390/ncrna7020037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Khezri MR. PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19. Hum Cell 2021;34:700-1. [PMID: 33432441 DOI: 10.1007/s13577-021-00484-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Khezri MR, Ghasemnejad-Berenji M. Neurological effects of elevated levels of angiotensin II in COVID-19 patients. Hum Cell 2021;34:1941-2. [PMID: 34449020 DOI: 10.1007/s13577-021-00605-0] [Reference Citation Analysis]
41 Khezri MR, Ghasemnejad-Berenji M, Mahboubi N. The probable mechanism of reduced androgen level in COVID-19 patients. Horm Mol Biol Clin Investig 2021. [PMID: 34674407 DOI: 10.1515/hmbci-2021-0052] [Reference Citation Analysis]
42 Chia KX, Polakhare S, Bruno SD. Possible affective cognitive cerebellar syndrome in a young patient with COVID-19 CNS vasculopathy and stroke. BMJ Case Rep 2020;13:e237926. [PMID: 33060143 DOI: 10.1136/bcr-2020-237926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
43 Stefanou M, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, Rizos E, Boutati E, Grigoriadis N, Krogias C, Giannopoulos S, Tsiodras S, Gaga M, Tsivgoulis G. Neurological manifestations of long-COVID syndrome: a narrative review. Therapeutic Advances in Chronic Disease 2022;13:204062232210768. [DOI: 10.1177/20406223221076890] [Reference Citation Analysis]
44 Shehata GA, Lord KC, Grudzinski MC, Elsayed M, Abdelnaby R, Elshabrawy HA. Neurological Complications of COVID-19: Underlying Mechanisms and Management. Int J Mol Sci 2021;22:4081. [PMID: 33920904 DOI: 10.3390/ijms22084081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Zaffina S, Lanteri P, Gilardi F, Garbarino S, Santoro A, Vinci MR, Carsetti R, Scorpecci A, Raponi M, Magnavita N, Camisa V. Recurrence, Reactivation, or Inflammatory Rebound of SARS-CoV-2 Infection With Acute Vestibular Symptoms: A Case Report and Revision of Literature. Front Hum Neurosci 2021;15:666468. [PMID: 34456694 DOI: 10.3389/fnhum.2021.666468] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Wang F, Kream RM, Stefano GB. Long-Term Respiratory and Neurological Sequelae of COVID-19. Med Sci Monit 2020;26:e928996. [PMID: 33177481 DOI: 10.12659/MSM.928996] [Cited by in Crossref: 18] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
47 Tan BH, Liu JM, Gui Y, Wu S, Suo JL, Li YC. Neurological involvement in the respiratory manifestations of COVID-19 patients. Aging (Albany NY) 2021;13:4713-30. [PMID: 33582654 DOI: 10.18632/aging.202665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Toniolo S, Scarioni M, Di Lorenzo F, Hort J, Georges J, Tomic S, Nobili F, Frederiksen KS; Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel. Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care. J Alzheimers Dis 2021;82:883-98. [PMID: 34092646 DOI: 10.3233/JAD-210335] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 DeKosky ST, Kochanek PM, Valadka AB, Clark RSB, Chou SH, Au AK, Horvat C, Jha RM, Mannix R, Wisniewski SR, Wintermark M, Rowell SE, Welch RD, Lewis L, House S, Tanzi RE, Smith DR, Vittor AY, Denslow ND, Davis MD, Glushakova OY, Hayes RL. Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients. J Neurotrauma 2021;38:1-43. [PMID: 33115334 DOI: 10.1089/neu.2020.7332] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
50 Żychowska M, Jaworecka K, Mazur E, Słomka K, Marszałek W, Rzepko M, Czarny W, Reich A. COVID-19 and Postural Control—A Stabilographic Study Using Rambling-Trembling Decomposition Method. Medicina 2022;58:305. [DOI: 10.3390/medicina58020305] [Reference Citation Analysis]
51 Hernández VS, Zetter MA, Guerra EC, Hernández-Araiza I, Karuzin N, Hernández-Pérez OR, Eiden LE, Zhang L. ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations. Exp Neurol 2021;345:113837. [PMID: 34400158 DOI: 10.1016/j.expneurol.2021.113837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Poyraz BM, Engin ED, Engin AB, Engin A. The effect of environmental diesel exhaust pollution on SARS-CoV-2 infection: The mechanism of pulmonary ground glass opacity. Environ Toxicol Pharmacol 2021;86:103657. [PMID: 33838330 DOI: 10.1016/j.etap.2021.103657] [Reference Citation Analysis]
53 Kumari P, Rothan HA, Natekar JP, Stone S, Pathak H, Strate PG, Arora K, Brinton MA, Kumar M. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice. Viruses 2021;13:132. [PMID: 33477869 DOI: 10.3390/v13010132] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 25.0] [Reference Citation Analysis]